Cumberland Pharmaceuticals (NSDQ:CPIX) said today that it acquired exclusive U.S. rights to Nordic Group‘s injectable methotrexate product line to treat rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriatic arthritis, and severe disabling psoriasis. Nordic Group has registered the product line for patient use in European countries, so Cumberland will register and commercialize the products in the U.S. […]
Pharmaceutical
PwC, California Life Sciences report highlights continued investment, growth
The California Life Sciences Assn. and PricewaterhouseCoopers released their annual Life Sciences Industry Report, highlighting continued growth and a robust pipeline of medical devices and other therapies in California this year. California, which is ranked 1st for medical device and biopharmaceutical employment in the country, saw 7% employment growth in the sector between 2011 and 2015. […]
Injectable opioid dependence treatment succeeds in clinical trial
Camarus AB (STO:CAMX) and Braeburn Pharmaceuticals said this week that a late-stage trial of its injectable opioid dependence treatment was successful. CMAX shares surged 16% at the beginning of the week following the announcement. The injectable buprenorphine therapy could be another treatment used to combat the growing opioid epidemic in the United States, which claimed the lives […]
Light-driven motor powers nanorobot drug delivery system
Researchers proposed a nanosized, light-driven motor that is powerful enough to carry a certain load and possible act as a drug delivery system, according to the study published in the Journal of Chemical Physics. “The unprecedented characteristics of dipole photomotors based on semiconductor nanoclusters offer the prospect of more than just addressing a certain scarcity of […]
China’s Uni-Bio Science, Luqa Pharmaceuticals ink deal for dermatology drug-device combos
Uni-Bio Science (HKG:0690) said today that it inked a strategic partnership with Luqa Pharmaceuticals for the marketing of dermatology drug-device combination products. According to the agreement, the China-based companies can co-promote drugs or medical devices for the treatment of dermatological disorders, including existing products. The 3-year promotion agreement, with an option to renew for 2 more years, enables […]
Are tiny ‘supermagnets’ the future of drug delivery?
Researchers from Quingdou University of Science and Technology in China developed a method to produce “supermagnets” that could one day be used as targeted drug delivery vehicles. The team’s work was published in Physics Letters A. Some magnetic materials are small enough that their magnetization randomly flips according to temperature; when scientists apply a magnetic field […]
Novo Nordisk’s Fiasp wins EU nod; Danish firm plans emerging markets push
Novo Nordisk (NYSE:NVO) said today that the European Union’s Committee for Medicinal Products for Human Use issued a positive opinion on its fast-acting insulin analogue, Fiasp. The Danish company also committed to expanding its Changing Diabetes in Children program, which provides access to diabetes care and free insulin to children with Type I diabetes in developing countries. The […]
Dow subsidiary presents transdermal delivery system
Dow (NYSE:DOW) subsidiary Dow Corning presented its latest drug delivery tech for transdermal therapies at the American Assn. of Pharmaceutical Sciences annual meeting. Dow Corning introduced its transdermal delivery patch, the SilAc Hybrid pressure-sensitive adhesive, which combine the properties of acrylic and silicone polymers. The Midland, Mich.-based company also featured its silicone-based topical ingredients with enhanced […]
California insurance board subpoenas Valeant
Valeant Pharmaceuticals (NYSE:VRX) said yesterday that it received an investigative subpoena from the California Dept. of Insurance last month over its ties to a specialty pharmacy, Philidor Rx Services. The company is facing allegations that it used Philidor to force customers to pay higher prices for its drugs. The subpoena reportedly asked for materials such as documents […]
Mylan misses on top & bottom lines, citing $465 million settlement
Shares in Mylan (NDSQ:MYL) rose slightly today after the pharmaceutical giant missed expectations on Wall Street with its 3rd-quarter results. The Canonsburg, Pa.-based company posted a net loss of -$119.8 million, or -23¢ per share, on sales of $3.06 billion for the 3 months ended Sept. 30, for a bottom-line slide of -3% on sales growth of 14.2% […]
Trump win boosts drug stocks
Pharmaceutical stocks surged today after Donald Trump won the U.S. presidential election, as investors concluded the threat of action on drug pricing had lessened. California’s Proposition 61, which would have prevented the state of California from purchasing drugs from a manufacturer for a price higher than that paid by the U.S. Veterans Affairs Dept., failed to […]